Germany
Update notification · 13.08.2026
Supply shortage: Nexviadyme
Affected country: Germany · Reported period: 03.07.2026 – 30.09.2026 · Active ingredient: Avalglucosidase alfa
CountryGermany
PZN00996123, 17309612, 17309629
ENR7002406, 7002407, 7002408
Notification typeUpdate notification
Start03.07.2026
Expected end30.09.2026
Last update13.08.2026
ReasonProduction problem
ATCA16AB22
Hospital-relevantYes
Notice context
A supply shortage has been recorded for Nexviadyme in Germany. The stated reason is “Production problem”. The notice concerns the active ingredient Avalglucosidase alfa and is identified as hospital-relevant.
This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.
Primary source: PharmNet.Bund / BfArM
Official shortage notice for Germany. Responsibility and update procedures follow the information supplied by the relevant authority.
Check the official notice list →